Kefang Liu
- Infectious Diseases top 2%
- Molecular Biology
- Immunology top 10%
- Animal Science and Zoology top 5%
- Oncology
- Topics
- SARS-CoV-2 and COVID-19 Research (25 papers)Animal Virus Infections Studies (13 papers)COVID-19 Clinical Research Studies (12 papers)
In The Last Decade
Kefang Liu
39 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 811
- Molecular Biology 280
- Immunology 228
- Animal Science and Zoology 194
- Oncology 153
Countries citing papers authored by Kefang Liu
This map shows the geographic impact of Kefang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefang Liu more than expected).
Fields of papers citing papers by Kefang Liu
This network shows the impact of papers produced by Kefang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefang Liu. The network helps show where Kefang Liu may publish in the future.
Co-authorship network of co-authors of Kefang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Kefang Liu. A scholar is included among the top collaborators of Kefang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefang Liu. Kefang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 23 | |
| 7 | 4 | |
| 8 | 7 | |
| 9 | 7 | |
| 10 | 3 | |
| 11 | 38 | |
| 12 | 13 | |
| 13 | 19 | |
| 14 | 5 | |
| 15 | 30 | |
| 16 | 66 | |
| 17 | 66 | |
| 18 | 123 | |
| 19 | 30 | |
| 20 | 25 |
About Kefang Liu
Kefang Liu is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (25 papers), Animal Virus Infections Studies (13 papers) and COVID-19 Clinical Research Studies (12 papers). The work is most often cited by research in Infectious Diseases (811 citations), Animal Science and Zoology (194 citations) and Immunology (228 citations). Kefang Liu has collaborated with scholars based in China, Macao and Czechia. Frequent co-authors include George F. Gao, William J. Liu, Min Zhao, Jianxun Qi, Kun Xu, Wenjie Tan, Gary Wong, Qihui Wang, Jinghua Yan and Shuguang Tan. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.